Published in Vaccine Weekly, July 20th, 2005
Study 1: Autoantibodies to redox-modified oligomeric A-beta are attenuated in the plasma of Alzheimer disease patients.
According to a study from the United States, "Accumulation of A-beta protein in beta-amyloid deposits is a hallmark event in Alzheimer disease (AD). Recent findings suggest anti-A-beta autoantibodies may have a role in AD pathology. However, a consensus has yet to emerge as to whether endogenous anti-A-beta autoantibodies are elevated, depressed, or unchanged in AD patients. Whereas experiments to date have used synthetic unmodified monomeric...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.